benzoxazoles has been researched along with trametinib in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnold, A; Chen, L; Clark, DJ; Eberhart, CG; Lih, TM; Maxwell, MJ; Raabe, EH; Rubens, JA; Schnaubelt, M; Sweeney, H; Zhang, H | 1 |
1 other study(ies) available for benzoxazoles and trametinib
| Article | Year |
|---|---|
Unbiased Proteomic and Phosphoproteomic Analysis Identifies Response Signatures and Novel Susceptibilities After Combined MEK and mTOR Inhibition in BRAF
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzoxazoles; Brain Neoplasms; Cell Line, Tumor; Female; Glioma; Humans; Mice, Nude; Mitogen-Activated Protein Kinase Kinases; Phosphoproteins; Protein Kinase Inhibitors; Proteomics; Proto-Oncogene Proteins B-raf; Pyridones; Pyrimidines; Pyrimidinones; TOR Serine-Threonine Kinases | 2021 |